Someone can do the numbers but this is massive for Relenza sales.
If only GSK could increase production quickly.
''HHS wants to increase the proportion of zanamivir (Relenza) in the national stockpile relative to oseltamivir (Tamiflu), in light of a few recent instances of H1N1 resistance to the latter. The current split is 80% oseltamivir and 20% zanamivir; the agency would like to move to 50-50, but that will take time.''
http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/jul1709board.html
- Forums
- ASX - By Stock
- BTA
- us to go to half relenza half tamiflu
us to go to half relenza half tamiflu
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online